Diabetes

Statin use for primary prevention was associated with reduced risk for all-cause and CV death among patients with hypertension and no other CVD or diabetes vs. matched controls not on statin therapy, researchers reported.

The prevalence of diabetic retinopathy in the U.S. remains high and may continue to grow due to the increase in diabetes in patients of all ages, according to a study published in JAMA Ophthalmology.

SAN DIEGO — A novel noninvasive blood glucose monitor may be able to measure glucose levels with an accuracy similar to fingersticks, according to a presenter.

SAN DIEGO — In this video exclusive, Richard Pratley, MD, discusses diabetes remission and the need for more information and clinical trials to understand the impact of remission on long-term outcomes.

Among people with diabetes, higher loneliness scores, but not isolation scores, were associated with greater risk for CVD, suggesting the quality but not quantity of relationships can impact disease risk, researchers reported.

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Tessa Cushman, RDN, about addressing health inequities for people living with diabetes who identify as LGBTQ+.

Researchers observed no increased risk for new-onset diabetes among IMPROVE-IT participants assigned to ezetimibe plus statin therapy vs. statin monotherapy, according to a research letter.

SAN DIEGO — Matthias Tschöp, MD, has played a major role in the recent influx of novel therapies for the treatment of diabetes and obesity.

SAN DIEGO — Oral semaglutide 50 mg induces more than 15% weight loss in adults with obesity at 68 weeks and can reduce HbA1c by 2 percentage points at 52 weeks for those with type 2 diabetes, according to data from two phase 3 trials.